Form 4: Pulmonx Executive Sells Shares
Insider Transaction (Form 4)
Srikanth Radhakrishnan, Chief Science & Techn. Officer of Pulmonx Corp, sold 14,245 shares of common stock on September 1, 2026 for $2.26 per share.
Summary
- Open-market sale: disposed of 2,643 Common Stock at $2.26 ($5,973) on September 1, 2026; holds 328,596 after (Direct).
- Open-market sale: disposed of 2,121 Common Stock at $2.26 ($4,793) on September 1, 2026; holds 326,475 after (Direct).
- Open-market sale: disposed of 3,618 Common Stock at $2.26 ($8,177) on September 1, 2026; holds 322,857 after (Direct).
- Open-market sale: disposed of 5,863 Common Stock at $2.26 ($13,250) on September 1, 2026; holds 316,994 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $32,194 of stock on the open market.
Insider Transactions
Srikanth Radhakrishnan — Officer (Chief Science & Techn. Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-09-01 | Open-market sale | Common Stock | 2,643 | $2 | $6.0K | 328,596 |
| 2026-09-01 | Open-market sale | Common Stock | 2,121 | $2 | $4.8K | 326,475 |
| 2026-09-01 | Open-market sale | Common Stock | 3,618 | $2 | $8.2K | 322,857 |
| 2026-09-01 | Open-market sale | Common Stock | 5,863 | $2 | $13.3K | 316,994 |
Key Dates
| Date | Description |
|---|---|
| 2026-09-01 | Open-market sale (2,643 shares) |
| 2026-09-01 | Open-market sale (2,121 shares) |
| 2026-09-01 | Open-market sale (3,618 shares) |
| 2026-09-01 | Open-market sale (5,863 shares) |
Keywords
insider transaction, Form 4, LUNG, Pulmonx Corp, bearish, Srikanth Radhakrishnan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.